Advertisement

FDA Will Subject Rapid Flu Tests to Tighter Regulation — Physician’s First Watch

Medical News |
May 23, 2014

FDA Will Subject Rapid Flu Tests to Tighter Regulation

By Joe Elia

Office-based tests for the rapid detection of influenza will shift from their "low-risk" classification to a higher-risk class that will mandate minimum clinical performance criteria and annual clinical testing, according to an FDA notice in the Federal Register and a report in The Hill.

The tests showed "poor performance" in the 2009 H1N1 pandemic, according to notes from an FDA advisory committee meeting held last June. Their performance "has often not matched the specifications provided in test labeling."

Given the serious public health implications of influenza outbreaks, tests not meeting the new requirements would be withdrawn from the market. Those requirements will include a sensitivity estimate of at least 90% for influenza A and 80% for influenza B; in addition, specificity must be at least 95%.

Reader Comments (1)

DrTeitelbaum@ezramedical.org Physician, Family Medicine/General Practice, EMC

Another layer of government oversight

JLT

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement